• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART VALVE Back to Search Results
Model Number 3000TFX
Device Problems Degraded (1153); Torn Material (3024); Appropriate Term/Code Not Available (3191)
Patient Problem Aortic Regurgitation (1716)
Event Date 08/22/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).Evaluation summary: the explanted device was returned to edwards for analysis.As received, minimal host tissue overgrowth encroached onto the tissue and into the orifice on leaflet 3 at the inflow aspect.The x-ray demonstrated moderate calcification on leaflet 1 and 2, one calcification nodule on leaflet 3, and an intact wireform.Leaflets were thickened and swollen along the commissures.Leaflet 1 had a non-transmural tear near commissure 2.Leaflet 2 had a tear along commissure 2, and a non-transmural tear along commissure 3.Leaflet 3 had a non-transmural tear along commissure 3.Thickened tissue was observed near the tears.(b)(4).Leaflet tears and leaflet disruptions occurring over time are a form of structural valve deterioration that may ultimately result in significant regurgitation requiring replacement of the valve.In this case, the clinical report of a torn leaflets were confirmed through visual observations of the returned device.Calcification plays a major role in the failure of bioprosthetic heart valves and can result in tearing or stenosis of the prosthesis.Many factors contribute to the onset and propagation of calcification including patient factors (age, disease state, pharmacological intervention, etc.) and mechanical stress related to the valve's hemodynamic performance.The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
Edwards received information that this 25mm bioprosthetic aortic heart valve was explanted after nine (9) years, seven (7) months due to severe aortic valve regurgitation, secondary to a torn leaflet.Upon visualization, the valve was noted to be severely degenerated with thickened valve leaflets.There was also severe dehiscence of approximately 50% of the valve ring away from the root.An aortic root replacement was performed and the valve was replaced.There were no reported complications and the patient was later discharged on post-operative day #5.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PERIMOUNT MAGNA PERICARDIAL BIOPROSTHESIS
Type of Device
REPLACEMENT HEART VALVE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
one edwards way
irvine CA 92614
Manufacturer Contact
neil landry
1 edwards way
ms: t&d 2nd floor, office t223
irvine, CA 92614
9492502289
MDR Report Key5954152
MDR Text Key54878705
Report Number2015691-2016-02758
Device Sequence Number1
Product Code DYE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860057/S022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 08/22/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/15/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/21/2008
Device Model Number3000TFX
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/29/2016
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/22/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/30/2006
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age66 YR
-
-